Adenoviral Pneumonia During Etanercept Treatment in a Patient with Rheumatoid Arthritis

Abstract

Inhibitors of tumor necrosis factor-alpha (TNF-alpha) have been approved for treating rheumatoid arthritis. As one of the biological response modifiers, etanercept has also been used in the treatment of psoriatic arthritis and inflammatory bowel disease. While etanercept is effective, certain infectious complications, such as tuberculosis, fungus, and… (More)

Topics

3 Figures and Tables

Cite this paper

@article{Kang2007AdenoviralPD, title={Adenoviral Pneumonia During Etanercept Treatment in a Patient with Rheumatoid Arthritis}, author={Min-Jung Kang and Myung-Sin Kim and Eun-Hwa Choi and Kyoung-Eun Lee and You-Kyoung Kim and Hee Jung Choi}, journal={The Korean Journal of Internal Medicine}, year={2007}, volume={22}, pages={63 - 66} }